Pharmaceutical companies

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

4 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

Healthcare, Pharma & Life Sciences 10 Oct 2026, 04:12 AM IST

GST Council Allows Pharma Firms to Claim Input Tax Credit on Free Samples, Expired Goods from FY28

The GST Council has approved a significant relief for pharmaceutical companies, allowing them to claim input tax credit on free samples and goods destroyed after expiry, effective from the next fiscal year. The move is expected to ease a long-standing tax burden on drugmakers and align GST treatment more closely with business realities in the sector.

By RDU Global Wire5 min read

Global Health & Biotech04 Oct 2026, 08:22 AM IST

Novartis Agrees to Up to $7.8 Billion mRNA Deal With China’s Abogen

Novartis has struck a licensing and development agreement with Chinese biotech Abogen Biosciences that could be worth as much as $7.8 billion, underscoring the Swiss drugmaker’s push into next-generation cancer therapies. The deal centers on an mRNA-encoded T-cell engager, a highly targeted approach that has drawn intense interest from large pharmaceutical companies seeking to replenish pipelines and deepen exposure to innovative Chinese science.

6 min readRead →

Macro Economy & Fiscal PolicyJust now (06:45 AM IST)

Cumulative FDI Surges to $843 Billion Amid Record Inflows in 2025-26

India's cumulative Foreign Direct Investment (FDI) has reached an unprecedented $843 billion from 2014 to 2026, with a record $94.53 billion inflow in the last fiscal year, according to Commerce and Industry Minister Piyush Goyal.

4 min readRead →

Markets, IPOs & WealthSept 26, 2026

Institutional Investors Boost Stakes in Nifty 500 Stocks, Driving Gains of Up to 40%

Foreign Institutional Investors (FIIs) and mutual funds have significantly increased their holdings in various Nifty 500 stocks during the June 2026 quarter, leading to remarkable share price gains of up to 41%. This trend reflects a growing confidence in the Indian market as institutional interest broadens across multiple sectors.

3 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Pharmaceutical companies:

Rajnath Singh(1)New Delhi(1)Indian Navy(1)India(1)GST Council(1)